The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
4-Thiazolidinones: The advances continue…
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radul, O. M., Bukhanyuk, S. M., Rekhter, M. D., Zhungietu, G. I., & Ivanova, I. (1982) · Cited by 10,653
General definition of ring puckering coordinates
Cremer, D., & Pople, J. A. (1975) · Journal of the American Chemical Society · doi:10.1021/ja00839a011 · Cited by 7,188
Hydrophobic, Highly Conductive Ambient-Temperature Molten Salts
Bonhôte, P., Dias, A.-P., Papageorgiou, N., Kalyanasundaram, K., & Grätzel, M. (1996) · Inorganic Chemistry · doi:10.1021/ic951325x · Cited by 4,358
Arzneimittelforschung: Eine Zukunftsoption für Ärzte?
Bethke, T. D. (2012) · Der Pneumologe · doi:10.1007/s10405-012-0601-3 · Cited by 3,261
Toxoplasma gondii: transmission, diagnosis and prevention
Hill, D., & Dubey, J. P. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00485.x · Cited by 1,173
Structure and Function of the CFTR Chloride Channel
SHEPPARD, D. N., & WELSH, M. J. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s23 · Cited by 1,018
Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1
Vassilev, L. T., Tovar, C., Chen, S., Knezevic, D., Zhao, X., Sun, H., Heimbrook, D. C., & Chen, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600447103 · Cited by 796
Matrix metalloproteinases (MMPs): Chemical–biological functions and (Q)SARs
Verma, R. P., & Hansch, C. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.011 · Cited by 783
Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic Pain
Miljanich, G. P. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043363884 · Cited by 607
Discovery and evaluation of inhibitors of human sphingosine kinase.
French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly, J. L., Yun, J. K., & Smith, C. D. (2003) · PubMed · Cited by 599
Wang, Z., Fermini, B., & Nattel, S. (1993) · Circulation Research · doi:10.1161/01.res.73.6.1061 · Cited by 574
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
Degterev, A., Lugovskoy, A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T., & Yuan, J. (2001) · Nature Cell Biology · doi:10.1038/35055085 · Cited by 550
Opportunities and Challenges in Antiparasitic Drug Discovery
Pink, R., Hudson, A., Mouriès, M.-A., & Bendig, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1824 · Cited by 545
Ma, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J. V., & Verkman, A. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216112 · Cited by 536
Targeted anti-mitotic therapies: can we improve on tubulin agents?
Jackson, J. R., Patrick, D. R., Dar, M. M., & Huang, P. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2049 · Cited by 473
Endothelial Dysfunction in Human Disease
Drexler, H., & Hornig, B. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0843 · Cited by 471
Structural biology of HIV 1 1Edited by P. E. Wright
Turner, B. G., & Summers, M. F. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2354 · Cited by 470
Recent developments and biological activities of thiazolidinone derivatives: A review
Jain, A. K., Vaidya, A., Ravichandran, V., Kashaw, S. K., & Agrawal, R. K. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.069 · Cited by 461
Role of CFTR in Airway Disease
PILEWSKI, J. M., & FRIZZELL, R. A. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s215 · Cited by 447
Challenges and successes in developing new therapies for hepatitis C
De Francesco, R., & Migliaccio, G. (2005) · Nature · doi:10.1038/nature04080 · Cited by 411
Küçükgüzel, Ş. G., Oruç‐Emre, E. E., Rollas, S., Şahin, F., & Özbek, A. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01326-5 · Cited by 407
PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer
Murphy, G. J., & Holder, J. C. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01559-5 · Cited by 386
Prevention and Treatment of the Complications of Diabetes Mellitus
Clark, C. M., & Lee, D. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321807 · Cited by 369
Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel
Saegusa, H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2349 · Cited by 364
Diverse mechanisms of antiepileptic drugs in the development pipeline
Rogawski, M. A. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.02.004 · Cited by 340
Küçükgüzel, G., Kocatepe, A., Clercq, E. D., Şahin, F., & Güllüce, M. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.11.005 · Cited by 325
Havrylyuk, D., Zimenkovsky, B. S., Vasylenko, O., Zaprutko, L., Gzella, A. K., & Lesyk, R. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.09.032 · Cited by 296
Vintonyak, V. V., Warburg, K., Kruse, H., Grimme, S., Hübel, K., Rauh, D., & Waldmann, H. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002138 · Cited by 294
The mechanisms of action of commonly used antiepileptic drugs
Kwan, P., Sills, G. J., & Brodie, M. J. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00122-x · Cited by 289
Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy
Grundy, S. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2005 · Cited by 287
Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs
Omar, K., Geronikaki, A., Zoumpoulakis, P., Camoutsis, C., Soković, M., Ćirić, A., & Glamočlija, J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.10.041 · Cited by 271
Bonde, C. G., & Gaikwad, N. J. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.02.024 · Cited by 252
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones
Bruno, G., Costantino, L., Curinga, C., Maccari, R., Monforte, F., Nicolò, F., Ottanà, R., & Vigorita, M. G. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00366-2 · Cited by 252
Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety
Havrylyuk, D., Мосула, Л. М., Zimenkovsky, B. S., Vasylenko, O., Gzella, A. K., & Lesyk, R. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.08.008 · Cited by 249
Chopra, I., Schofield, C., Everett, M., O'Neill, A., Miller, K., Wilcox, M., Frère, J.-M., Dawson, M., Czaplewski, L., Urleb, U., et al. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70018-5 · Cited by 243
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents
Barreca, M. L., Chimirri, A., De Luca, L., Monforte, A.-M., Monforte, P., Rao, A., Zappalà, M., Balzarini, J., De Clercq, E., Pannecouque, C., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00304-3 · Cited by 235
Kauppi, A. M., Nordfelth, R., Uvell, H., Wolf-Watz, H., & Elofsson, M. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00046-2 · Cited by 232
Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century
Alexiou, P., Pegklidou, K., Chatzopoulou, M., Nicolaou, I., & Demopoulos, V. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787458362 · Cited by 232
Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
Xia, Z., Knaak, C., Ma, J., Beharry, Z. M., McInnes, C., Wang, W., Kraft, A. S., & Smith, C. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800937p · Cited by 194
Rhodanine derivatives as inhibitors of JSP-1
Cutshall, N. S., O’Day, C., & Prezhdo, M. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.034 · Cited by 193
Mitotic drug targets and the development of novel anti-mitotic anticancer drugs
Schmidt, M., & Bastians, H. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.06.003 · Cited by 186
Gazzard, B., & Graeme, G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04084-7 · Cited by 185
Kamel, M. M., Ali, H. I., Anwar, M. M., Mohamed, N. A., & Soliman, A. M. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.10.044 · Cited by 180
2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1Receptor Agonists
Bolli, M. H., Abele, S., Binkert, C., Bravo, R., Buchmann, S., Bur, D., Gatfield, J., Hess, P., Kohl, C., Mangold, C., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100181s · Cited by 179
Zhou, H., Wu, S., Zhai, S., Liu, A., Sun, Y., Li, R., Zhang, Y., Ekins, S., Swaan, P. W., Fang, B., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7012024 · Cited by 179
New Small-Molecule Synthetic Antimycobacterials
Ballell, L., Field, R. A., Duncan, K., & Young, R. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2153-2163.2005 · Cited by 177
An Inhibitor of Gram-Negative Bacterial Virulence Protein Secretion
Felise, H. B., Nguyen, H. V., Pfuetzner, R. A., Barry, K. C., Jackson, S. R., Blanc, M.-P., Bronstein, P. A., Kline, T., & Miller, S. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.08.001 · Cited by 163
Carter, P. H., Scherle, P., Muckelbauer, J. A., Voss, M. E., Liu, R., Thompson, L. A., Tebben, A. J., Solomon, K. A., Lo, Y. C., Li, Z., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211178398 · Cited by 159
Ca, P. (1976) · PubMed · Cited by 157
Keyser, P. D., Elofsson, M., Rosell, S., & Wolf‐Watz, H. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01941.x · Cited by 154
Ottanà, R., Carotti, S., Maccari, R., Landini, I., Chiricosta, G., Caciagli, B., Vigorita, M. G., & Mini, E. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.093 · Cited by 154
New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: Synthesis and anticancer evaluation
Lesyk, R., Vladzimirska, O., Holota, S. M., Zaprutko, L., & Gzella, A. K. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.12.006 · Cited by 153
Control of Hepatitis C: A Medicinal Chemistry Perspective
Gordon, C. P., & Keller, P. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0400101 · Cited by 145
The GPI biosynthetic pathway as a therapeutic target for African sleeping sickness
Ferguson, M. A. J., Brimacombe, J. S., Brown, J. R.-M., Crossman, A., Dix, A. P., Field, R. A., Güther, M. L. S., Milne, K. G., Sharma, D. K., & Smith, T. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00058-7 · Cited by 143
Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives
Patil, V., Tilekar, K. N., Mehendale-Munj, S., Mohan, R., & Ramaa, C. S. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.07.014 · Cited by 141
Nonaminoglycoside compounds induce readthrough of nonsense mutations
Du, L., Damoiseaux, R. D., Nahas, S., Gao, K., Hu, H., Pollard, J. M., Goldstine, J. V., Jung, M. E., Henning, S. M., Bertoni, C., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20081940 · Cited by 139
Chemical Probes of UDP-Galactopyranose Mutase
Carlson, E. E., May, J. F., & Kiessling, L. L. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.06.007 · Cited by 130
Discovery of Small Molecule Integrin αvβ3 Antagonists as Novel Anticancer Agents
Dayam, R., Aiello, F., Deng, J. N., Wu, Y., Garofalo, A., Chen, X. S., & Neamati, N. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051296s · Cited by 128
Cardiac Ultrarapid Delayed Rectifiers
Nattel, S., Yue, L., & Wang, Z. (1999) · Cellular Physiology and Biochemistry · doi:10.1159/000016318 · Cited by 122
Maccari, R., Ottanà, R., Curinga, C., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.02.026 · Cited by 120
Ottanà, R., Maccari, R., Giglio, M., CORSO, A. D., Cappiello, M., Mura, U., Cosconati, S., Marinelli, L., Novellino, E., Sartini, S., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.03.068 · Cited by 118
Negrea, A., Bjur, E., Ygberg, S. E., Elofsson, M., Wolf‐Watz, H., & Rhen, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00223-07 · Cited by 115
Torlone, E., Rambotti, A. M., Perriello, G., Botta, G., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1991) · Diabetologia · doi:10.1007/bf00500383 · Cited by 114
Altered channel gating mechanism for CFTR inhibition by a high‐affinity thiazolidinone blocker
Taddei, A., Folli, C., Zegarra‐Moran, O., Fanen, P., Verkman, A. S., & Galietta, L. J. V. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00011-0 · Cited by 112
Liesen, A. P., de Aquino, T. M., Carvalho, C. S., Lima, V. T., de Araújo, J. M., de Lima, J. G., de Faria, A. R., de Melo, É. J. T., Alves, A. J., Alves, E. W., et al. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.05.017 · Cited by 110
Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors
Nuti, E., & Tuccinardi, T. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781039706 · Cited by 109
Geronikaki, A. A., Eleftheriou, P. T., Vicini, P., Alam, I., Dixit, A., & Saxena, A. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8004306 · Cited by 108
Bhati, S. K., & Kumar, A. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.10.012 · Cited by 106
Lesyk, R., Zimenkovsky, B. S., Atamanyuk, D. V., Jensen, F., Kieć‐Kononowicz, K., & Gzella, A. K. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.03.053 · Cited by 102
Synthesis and in vitro anticancer activity of 2,4-azolidinedione-acetic acids derivatives
Kaminskyy, D. V., Zimenkovsky, B. S., & Lesyk, R. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.02.023 · Cited by 100
Novel 6,8-dibromo-4(3H)quinazolinone derivatives of anti-bacterial and anti-fungal activities
Mohamed, M. S., Kamel, M. M., Kassem, E. M. M., Abotaleb, N., El‐Moez, S. I. A., & Ahmed, M. F. E. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.04.014 · Cited by 96
Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity
Subtel’na, I., Atamanyuk, D. V., Szymańska, E., Kieć‐Kononowicz, K., Zimenkovsky, B. S., Vasylenko, O., Gzella, A. K., & Lesyk, R. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.073 · Cited by 94
Microtubule-targeting agents in angiogenesis: Where do we stand?
Pasquier, E., Honoré, S., & Braguer, D. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.04.003 · Cited by 89
Eleftheriou, P. T., Geronikaki, A. A., Hadjipavlou‐Litina, D., Vicini, P., Filz, O., Filimonov, D. A., Poroikov, V., Chaudhaery, S. S., Roy, K. K., & Saxena, A. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.10.029 · Cited by 88
Targeting Matrix Metalloproteinases in Inflammatory Conditions
Clutterbuck, A. L., Asplin, K. E., Harris, P., Allaway, D., & Mobasheri, A. (2009) · Current Drug Targets · doi:10.2174/138945009789753264 · Cited by 87
Zhang, Q., Zhou, H., Zhai, S., & Yan, B. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208983 · Cited by 81
Ottanà, R., Mazzon, E., Dugo, L., Monforte, F., Maccari, R., Sautebin, L., Luca, G. D., Vigorita, M. G., Alcaro, S., Ortuso, F., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01888-5 · Cited by 73
A Bioinorganic Perspective on Matrix Metalloproteinase Inhibition
Puerta, D. T., & Cohen, S. M. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387368 · Cited by 68
Zentgraf, M., Steuber, H., von Koch, C. S., Motta, C. L., Sartini, S., Sotriffer, C., & Klebe, G. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200603625 · Cited by 67
Arnold, E., Das, K., Ding, J., Yadav, P. N., Hsiou, Y., Boyer, P. L., & Hughes, S. H. (1996) · PubMed · Cited by 63
Synthesis and Anticancer and Antiviral Activities of New 2‐Pyrazoline‐Substituted 4‐Thiazolidinones
Havrylyuk, D., Zimenkovsky, B. S., Vasylenko, O., & Lesyk, R. (2013) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.1056 · Cited by 61
Evaluation of in vitro aldose redutase inhibitory activity of 5-arylidene-2,4-thiazolidinediones
Maccari, R., Ottanà, R., Ciurleo, R., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.04.109 · Cited by 59
Smith, T., Young, B. L., Denton, H., Hughes, D. L., & Wagner, G. K. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.083 · Cited by 59
Chen, S., Chen, L., Le, N. T., Zhao, C., Sidduri, A., Lou, J. P., Michoud, C., Portland, L., Jackson, N., Liu, J., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.081 · Cited by 57
Sonawane, N. D., & Verkman, A. S. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.044 · Cited by 54
Synthesis and antibiofilm activity of marine natural product-based 4-thiazolidinones derivatives
Rane, R. A., Sahu, N. U., & Shah, C. P. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.073 · Cited by 52
Nampurath, G. K., Mathew, S. P., Khanna, V., Zachariah, R. T., Kanji, S., & Chamallamudi, M. R. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.10.006 · Cited by 50
Teraishi, F., Wu, S., Sasaki, J., Zhang, L., Zhu, H.-B., Davis, J. J., & Fang, B. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085654 · Cited by 45
Li, Q., Wu, J., Zheng, H., Liu, K., Guo, T. L., Liu, Y., Eblen, S. T., Grant, S., & Zhang, S. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.030 · Cited by 40
4-Thiazolidinones: a novel class of hepatitis C virus NS5B polymerase inhibitors
Kaushik‐Basu, N., Waffo, A. B., Talele, T. T., Basu, A., Chen, Y., & Küçükgüzel, Ş. G. (2008) · Frontiers in bioscience · doi:10.2741/2974 · Cited by 36
Kato, T., Ozaki, T., Tamura, K., Suzuki, Y., Akima, M., & Ohi, N. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980335f · Cited by 34
Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias
Jackson, C. M., Blass, B. E., Coburn, K. R., Djandjighian, L., Fadayel, G. M., Fluxe, A., Hodson, S. J., Janusz, J. M., Murawsky, M. K., Ridgeway, J. M., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.007 · Cited by 34
Calderone, V., Rapposelli, S., Martelli, A., Digiacomo, M., Testai, L., Torri, S., Marchetti, P., Breschi, M. C., & Balsamo, A. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.06.049 · Cited by 32
Kishore, A., Nampurath, G. K., Mathew, S. P., Zachariah, R. T., Potu, B. K., Rao, M. S. R., Valiathan, M., & Chamallamudi, M. R. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.032 · Cited by 32
Kaminskyy, D. V., Khyluk, D., Vasylenko, O., & Lesyk, R. (2011) · Tetrahedron Letters · doi:10.1016/j.tetlet.2011.11.095 · Cited by 28
Desai, N. C., Joshi, V. V., Rajpara, K. M., Vaghani, H., & Satodiya, H. M. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0190-z · Cited by 19
Anti‐Microbial Activity and Film Characterization of Thiazolidinone Derivatives of Chitosan
Kulkarni, A. R., Kulkarni, V. H., Keshavayya, J., Hukkeri, V. I., & Sung, H. (2005) · Macromolecular Bioscience · doi:10.1002/mabi.200400207 · Cited by 18
Follicle stimulating hormone and its receptor: future perspectives
Chappel, S. C., Buckler, D. R., Kelton, C., & Tayar, N. E. (1998) · Human Reproduction · doi:10.1093/humrep/13.suppl_3.18 · Cited by 14
Metadata
- Authors
- Tripathi, A. C., Gupta, S. J., Fatima, G. N., Sonar, P. K., Verma, A., & Saraf, S. K.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 72
- Pages
- 52-77
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2052434638
- Cited by
- 319
- References
- 99
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.